Regeneron Pharmaceuticals
REGN
#279
Rank
$79.01 B
Marketcap
$745.48
Share price
2.65%
Change (1 day)
-3.83%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Cash on Hand

Cash on Hand as of September 2025 : $8.44 Billion USD

According to Regeneron Pharmaceuticals's latest financial reports the company has $8.44 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Regeneron Pharmaceuticals - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$9.01 B-16.9%
2023-12-31$10.84 B40.07%
2022-12-31$7.74 B35.96%
2021-12-31$5.69 B58.76%
2020-12-31$3.58 B11.6%
2019-12-31$3.21 B14.39%
2018-12-31$2.80 B99.35%
2017-12-31$1.40 B35.7%
2016-12-31$1.03 B-0.63%
2015-12-31$1.04 B16.07%
2014-12-31$0.90 B29.76%
2013-12-31$0.69 B125.25%
2012-12-31$0.30 B-41.53%
2011-12-31$0.52 B111.31%
2010-12-31$0.24 B-26.94%
2009-12-31$0.34 B-28.1%
2008-12-31$0.47 B-38.06%
2007-12-31$0.76 B66.88%
2006-12-31$0.45 B53.84%
2005-12-31$0.29 B0.87%
2004-12-31$0.29 B0.75%
2003-12-31$0.29 B11.16%
2002-12-31$0.26 B-31.37%
2001-12-31$0.38 B227.41%
2000-12-31$0.11 B77.66%
1999-12-31$66.2 M234.34%
1998-12-31$19.8 M-31.49%
1997-12-31$28.9 M-16.23%
1996-12-31$34.5 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
$9.44 B 11.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$2.72 B-67.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$3.96 B-53.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$18.56 B 119.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$9.75 B 15.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
$10.45 B 23.78%๐Ÿ‡ซ๐Ÿ‡ท France